1. 136 Complete Resection of Contrast-Enhancing Tumor Volume is Associated With Improved Survival in Recurrent Glioblastoma Results From the DIRECTOR Trial. (August 2015) Authors: Suchorska, Bogdana; Weller, Michael; Tabatabai, Ghazaleh; Senft, Christian; Hau, Peter; Sabel, Michael; Herrlinger, Ulrich; Ketter, Ralf; Schlegel, Uwe; Marosi, Christine; Reifenberger, Guido; Wick, Wolfgang; Tonn, Joerg-Christian; Wirsching, Hans-Georg Journal: Clinical neurosurgery Issue: Volume 62(2015)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 468 Enhancers and repressors of immunotherapy: translational perspectives on gene-mediated cytotoxic immunotherapy in glioblastoma. (9th November 2020) Authors: Lawler, Sean; Koch, Marilin; Zdioruk, Mikolay; Aguilar-Cordova, Estuardo; Aguilar, Laura; Guzik, Brian; Tabatabai, Ghazaleh; Nowicki, Michal; Antonio Chiocca, E Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A498 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 468 Enhancers and repressors of immunotherapy: translational perspectives on gene-mediated cytotoxic immunotherapy in glioblastoma. (9th November 2020) Authors: Lawler, Sean; Koch, Marilin; Zdioruk, Mikolay; Aguilar-Cordova, Estuardo; Aguilar, Laura; Guzik, Brian; Tabatabai, Ghazaleh; Nowicki, Michal; Antonio Chiocca, E Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A286 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. ACTR-16. PERIPHERAL BLOOD CD4+ MONONUCLEAR CELL FRACTIONS ARE ASSOCIATED WITH OVERALL SURVIVAL AT FIRST RECURRENCE OF IDH-WILDTYPE GLIOBLASTOMA AFTER STANDARD CHEMORADIOTHERAPY: SECONDARY ANALYSES OF THE PHASE II DIRECTOR TRIAL. (5th November 2018) Authors: Wirsching, Hans-Georg; Terksikh, Ekaterina; Silginer, Manuela; Krieg, Carsten; Tabatabai, Ghazaleh; Wick, Wolfgang; Reifenberger, Guido; Roth, Patrick; Becher, Burkhard; Weller, Michael Journal: Neuro-oncology Issue: Volume 20(2018)Supplement 6 Page Start: vi14 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. ACTR-31. THE USE OF TTFIELDS FOR NEWLY DIAGNOSED GBM PATIENTS IN GERMANY IN ROUTINE CLINICAL CARE (TIGER: TTFIELDS IN GERMANY IN ROUTINE CLINICAL CARE). (11th November 2019) Authors: Bähr, Oliver; Tabatabai, Ghazaleh; Fietkau, Rainer; Goldbrunner, Roland; Glas, Martin Journal: Neuro-oncology Issue: Volume 21(2019)Supplement 6 Page Start: vi20 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. ACTR-74. A PHASE IB/II, OPEN-LABEL, MULTICENTER STUDY OF CAPMATINIB (INC280) ALONE AND IN COMBINATION WITH BUPARLISIB (BKM120) IN ADULT PATIENTS WITH RECURRENT GLIOBLASTOMA. Issue 11 (6th November 2017) Authors: van den Bent, Martin; Azaro, Analia; Vos, Filip; Sepulveda, Juan; Yung, W K Alfred; Wen, Patrick; Lassman, Andrew; Joerger, Markus; Tabatabai, Ghazaleh; Rodon, Jordi; Tiedt, Ralph; Zhao, Sylvia; Kirsilae, Tiina; Vicente, Sergio; Myers, Andrea; Wick, Wolfgang Journal: Neuro-oncology Issue: Volume 19:Issue 11(2017)supplement 6 Page Start: vi16 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Advances in multidisciplinary therapy for meningiomas. (14th January 2019) Authors: Brastianos, Priscilla K; Galanis, Evanthia; Butowski, Nicholas; Chan, Jason W; Dunn, Ian F; Goldbrunner, Roland; Herold-Mende, Christel; Ippen, Franziska M; Mawrin, Christian; McDermott, Michael W; Sloan, Andrew; Snyder, James; Tabatabai, Ghazaleh; Tatagiba, Marcos; Tonn, Joerg C; Wen, Patrick Y;... Journal: Neuro-oncology Issue: Volume 21(2019)Supplement 1 Page Start: i18 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Argyrin F Treatment‐Induced Vulnerabilities Lead to a Novel Combination Therapy in Experimental Glioma. Issue 9 (19th June 2021) Authors: Walter, Bianca; Canjuga, Denis; Yüz, Simge G.; Ghosh, Michael; Bozko, Przemyslaw; Przystal, Justyna M.; Govindarajan, Parameswari; Anderle, Nicole; Keller, Anna‐Lena; Tatagiba, Marcos; Schenke‐Layland, Katja; Rammensee, Hans‐Georg; Stevanovic, Stefan; Malek, Nisar P.; Schmees, Christian; Tabataba... Journal: Advanced therapeutics Issue: Volume 4:Issue 9(2021) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. ATIM-33. NOA-16: A FIRST-IN-MAN MULTICENTER PHASE I CLINICAL TRIAL OF THE GERMAN NEUROONCOLOGY WORKING GROUP EVALUATING A MUTATION-SPECIFIC PEPTIDE VACCINE TARGETING IDH1R132H IN PATIENTS WITH NEWLY DIAGNOSED MALIGNANT ASTROCYTOMAS. (5th November 2018) Authors: Platten, Michael; Schilling, Daniela; Bunse, Lukas; Wick, Antje; Bunse, Theresa; Riehl, Dennis; Green, Edward; Sanghvi, Khwab; Karapanagiotou-Schenkel, Irini; Harting, Inga; Sahm, Felix; Steinbach, Joachim; Weyerbrock, Astrid; Hense, Jörg; Misch, Martin; Krex, Dietmar; Stevanovic, Stefan; Tabatab... Journal: Neuro-oncology Issue: Volume 20(2018)Supplement 6 Page Start: vi8 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. ATRT-12. LIN28A expression correlates with poor prognosis and the MYC subgroup in AT/RTs. (3rd June 2022) Authors: Dottermusch, Matthias; Brakopp, Sina; Struve, Nina; Frühwald, Michael C; Merk, Daniel J; Tabatabai, Ghazaleh; Schüller, Ulrich; Hasselblatt, Martin; Neumann, Julia E Journal: Neuro-oncology Issue: Volume 24(2022)Supplement 1 Page Start: i5 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗